Life science pharmaceutical and drug development.
Cofactor Genomics uses RNA to diagnose disease. Their team of past Human Genome Project Scientists have created RNA based tests that are enabling drug companies to develop new drugs. Their tests will help physicians make personalized medicine a reality. They are providing valuable and unique diagnostics and disease monitoring for the 95% of diseases that can not be diagnosed by DNA. Cofactor s molecular detection technology allows us to detect specific RNAs 100X more sensitively than current methods and the result is they are detecting key molecules indicating disease. This molecular technology paired with Cofactor s Machine Learning based software is paving the way for new diagnostics that achieve the signal to noise separation necessary to make RNA based diagnostics a reality. They currently have the largest database of RNA profiles.
|Other||11 - 50 employees|
Funding and Financing Rounds
Impact Reports & Metrics
600 California St
San Francisco, California 94109
United States of America